Does Syndax (SNDX) Have the Potential to Rally 158.36% as Wall Street Analysts Expect?

Syndax Pharmaceuticals (SNDX) closed the last trading session at $13.45, gaining 45.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 34.75 indicates a 158.4% upside potential.The mean estimate comprises 12 short-term price targets with a standard deviation of $12.74. While the lowest estimate of$ 17.00 indicates a 26.4% increase from the current price level, the most optimistic ...